Redwood Park Advisors LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Redwood Park Advisors LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 113 shares of the healthcare conglomerate’s stock, valued at approximately $57,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Howard Capital Management Group LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at $341,000. Principal Financial Group Inc. raised its position in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $319,000. Executive Wealth Management LLC raised its position in shares of UnitedHealth Group by 6.6% during the 3rd quarter. Executive Wealth Management LLC now owns 1,088 shares of the healthcare conglomerate’s stock valued at $636,000 after buying an additional 67 shares in the last quarter. Finally, Empire Financial Management Company LLC grew its holdings in shares of UnitedHealth Group by 0.9% during the 3rd quarter. Empire Financial Management Company LLC now owns 4,216 shares of the healthcare conglomerate’s stock valued at $2,465,000 after purchasing an additional 37 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. 0.33% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on UNH shares. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Mizuho lifted their price target on UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday. Barclays reduced their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Twenty-one analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $630.35.

UnitedHealth Group Stock Up 4.9 %

Shares of UNH opened at $580.16 on Thursday. The firm has a market capitalization of $530.68 billion, a price-to-earnings ratio of 37.43, a PEG ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The business’s fifty day moving average price is $510.86 and its two-hundred day moving average price is $541.73. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. The firm’s revenue was up 6.8% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.45%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.